The in vitro activity of cefoperazone against 380 strains (33 species and unnamed groups) of nonfermenters and 20 strains of Aeromonas hydrophila was studied by a microdilution method of determining minimal inhibitory concentrations. For comparison, the activities of ampicillin, ticarcillin, and cefamandole were simultaneously studied. Cefoperazone was the most active drug against Pseudomonas sp., Achromobacter xylosoxidans, Flavobacterium meningosepticum, Flavobacterium sp. (group HIb), Group IVc biotype 2, Group Ve, and Aeromonas hydrophila. Against other organisms it was equivalent in activity to or less active than comparative antibiotics. The only organisms which were usually resistant to 128 ,tg of cefoperazone per ml were strains of Flavobacterium odoratum and Group IIk biotype 1. Cefoperazone is a new cephalosporin antibiotic which is more active than commercially available 83-lactam antibiotics against most strains of Enterobacteriaceae and Pseudomonas aeruginosa (4) (5) (6) (7) (8) (9) . It also has significant activity against gram-positive cocci other than enterococci (4-6, 8, 9) , Haemophilus influenzae (1, 9), Neisseria gonorrhoeae (1, 4, 9) , and some anaerobes (3, 6, 9) . The purpose of this study was to test the activity of cefoperazone against a variety of nonfermenters and Aeromonas hydrophila. For comparison, ampicillin, ticarcillin, and cefamandole were simultaneously studied.
Organisms. The organisms studied included 400 clinical isolates (Table 1) which were identified as previously described (2). When related organisms had similar susceptibility patterns, they were grouped together.
Antibiotics. Cefoperazone was obtained from Pfizer Inc., Groton, Conn., ampicillin and ticarcillin were obtained from Beecham Products, Pittsburgh, Pa. and cefamandole was obtained from Eli Lilly & Co., Indianapolis, Ind. Laboratory standards were diluted as recommended by manufacturers to stock concentrations of 1, 280 Ag/ml and used immediately or frozen at -20°C for up to a maximum of 1 
